This week, courts are examining the potential cessation of telemedicine access to mifepristone, one of the two medications commonly used in medication abortions.
The outcome of these legal discussions could significantly affect how patients obtain this medication, particularly in a telehealth context.
As the situation evolves, it remains crucial to stay informed about the implications for reproductive health access and the ongoing legal landscape.